Xylem (XYL) Cost Of Revenue (2016 - 2025)
Historic Cost of Revenue for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $1.4 billion.
- Xylem's Cost of Revenue rose 492.42% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 340.67%. This contributed to the annual value of $5.4 billion for FY2024, which is 1512.8% up from last year.
- Per Xylem's latest filing, its Cost of Revenue stood at $1.4 billion for Q3 2025, which was up 492.42% from $1.4 billion recorded in Q2 2025.
- In the past 5 years, Xylem's Cost of Revenue ranged from a high of $1.4 billion in Q2 2025 and a low of $766.0 million during Q1 2021
- Over the past 5 years, Xylem's median Cost of Revenue value was $1.1 billion (recorded in 2023), while the average stood at $1.1 billion.
- Its Cost of Revenue has fluctuated over the past 5 years, first tumbled by 200.71% in 2021, then soared by 5327.1% in 2023.
- Quarter analysis of 5 years shows Xylem's Cost of Revenue stood at $830.0 million in 2021, then grew by 12.41% to $933.0 million in 2022, then soared by 45.98% to $1.4 billion in 2023, then rose by 2.72% to $1.4 billion in 2024, then decreased by 1.0% to $1.4 billion in 2025.
- Its last three reported values are $1.4 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.3 billion during Q1 2025.